Company / Free Cash Flow per Share
SELLAS Life Sciences Group, Inc. Free Cash Flow per Share History
FY2015-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.46
FY2016
5-year range
-
FY2015-FY2016
Trend
-231.7%
vs FY2015
Sector context
#123 of 192
Health Care
What the data says
At $-1.46, SELLAS Life Sciences Group, Inc.'s free cash flow per share ranks #123 of 192 in the Health Care sector.
Based on SEC 10-K filings.
-1.46 in FY2016.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#123 of 192 in Health CareTop 64% of 192This company -$1.46 Sector average -$19.84
▼
+92.6% above sector average
Key checks
Key Insights
- In FY2016, free cash flow per share decreased 231.7% year-over-year.
- Ranks #123 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$1.46 | -231.7% |
| FY2015 | -$0.44 | -12.5% |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026